drugset / Trial / NCT05731778

Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis

NCT05731778

Phase 4 Completed 26 enrolled Colgate Palmolive
RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluate a stannous technology for its effect on the neutrophil phenotype during an induced gingivitis state.

Timeline

Start
2018-12-22
Primary completion
2020-12-22
Completion
2020-12-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium monofluorophosphate Unknown 0.76 %
Subject stannous fluoride Small molecule 0.454 %

Indications